Related Experiment Video
Updated: Sep 11, 2025
04:48
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
Published on: March 1, 2024
2.0K
Smarter stem cells: how AI is supercharging iPSC technology
1Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt. hanymarei@mans.edu.eg.
Cell and Tissue Research
|August 13, 2025
Summary
Artificial intelligence (AI) enhances induced pluripotent stem cell (iPSC) technology for disease modeling and regenerative medicine. This integration accelerates research, improves patient-specific treatments, and transforms healthcare.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Artificial Intelligence
Background:
- Induced pluripotent stem cell (iPSC) technology is crucial for disease modeling and regenerative medicine.
- Artificial intelligence (AI) offers advanced capabilities in data analysis and predictive modeling for biomedical research.
Purpose of the Study:
- To examine the advancements and impact of integrating AI with iPSC technology.
- To explore how AI enhances iPSC applications in disease modeling, cellular biology, and pharmaceutical development.
- To discuss the challenges and future possibilities of AI in iPSC research.
Main Methods:
- Review of current literature on AI applications in iPSC technology.
- Analysis of AI's role in improving iPSC differentiation, culture conditions, and disease-specific model development.
- Examination of AI-driven omics database analysis for personalized medicine.
Main Results:
- AI integration significantly enhances iPSC-based technologies, improving disease modeling and drug development.
- AI facilitates the creation of patient-specific cell types and accelerates the development of customized treatments.
- AI-driven omics analysis uncovers biological insights, paving the way for precision healthcare.
Conclusions:
- AI is a transformational technology in stem cell research, revolutionizing regenerative medicine and precision healthcare.
- Addressing challenges in AI algorithms and data quality is key to unlocking the full potential of AI in iPSC applications.
- The synergy between AI and iPSC technology promises to fundamentally alter therapeutic strategies and patient care.
Keywords:
AICellular reprogrammingDLDifferentiation protocolsDisease modelingDrug discoveryHigh-content imagingInduced pluripotent stem cells (iPSCs)ML(ML)Multi-omicsPersonalized medicinePredictive modelingRegenerative medicineReinforcement learningTranscriptomicsMore Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:13Induced Pluripotent Stem Cells
24.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.4K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:29Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K